Mode
Text Size
Log in / Sign up

Meta-analysis finds non-linear exercise dose-response for mobility in stroke patients aged 45+Exercise dose matters for mobility in stroke patients, but optimal amounts vary by type

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider modality-specific exercise dose zones for mobility in stroke rehab, but note virtual reality evidence remains inconclusive.

This Bayesian dose-response meta-analysis synthesized data from 25 randomized controlled trials involving 788 middle-aged and older adults (aged ≥45 years) with stroke. The analysis examined the association between exercise dose (measured in MET·min/week) and improvement in lower-limb functional mobility assessed via the Timed Up and Go test across various exercise modalities including gait training, motor control training, resistance training, integrated aerobic training, combined cognitive-exercise training, and virtual reality training.

The analysis revealed a non-linear association between overall exercise dose and mobility improvement, with peak effect (standardized mean difference ≈0.45) occurring at approximately 1400 MET·min/week. However, optimal dose zones varied substantially by exercise modality: resistance and gait training showed strong effects at lower doses (~560 MET·min/week), motor control training achieved significant effects at moderate doses (~890 MET·min/week, SMD ~0.50), while integrated aerobic and combined cognitive-exercise training peaked at higher doses (~1700-1800 MET·min/week). Virtual reality training exhibited wide credible intervals and non-significant effects.

Safety and tolerability data were not reported in the aggregated analysis. Key limitations include the Bayesian modeling approach, which relies on aggregated trial data rather than individual patient data, and the inability to establish causality from this meta-analytic design. The evidence for virtual reality training remains inconclusive due to wide credible intervals. While this analysis provides quantitative guidance for dose-informed exercise prescriptions in neurorehabilitation, clinicians should interpret the optimal dose zones cautiously and consider individual patient factors when implementing these findings.

Researchers analyzed data from 25 randomized controlled trials involving middle-aged and older adults with stroke. The study looked at how the total amount of exercise and the specific type of training influenced lower-limb functional mobility. The primary measure used was the Timed Up and Go test, which assesses how quickly a person can stand, walk, turn, and sit down.

The analysis found a non-linear relationship between exercise dose and improvement. Overall, the greatest benefit occurred at approximately 1400 MET-minutes per week. However, the ideal amount of exercise depended on the specific modality used. For example, resistance and gait training showed strong effects at lower doses around 560 MET-minutes per week.

Other types of training also showed benefits at different levels. Motor control training achieved significant effects at moderate doses near 890 MET-minutes per week. Integrated aerobic and combined cognitive-exercise training peaked at higher doses between 1700 and 1800 MET-minutes per week. In contrast, virtual reality training showed wide credible intervals and non-significant effects, indicating the evidence for this method is currently inconclusive.

No safety concerns or adverse events were reported in the included trials. The study provides quantitative guidance for creating individualized exercise prescriptions in neurorehabilitation. However, readers should be cautious about generalizing these specific dose zones to populations or exercise types not studied. The findings are based on Bayesian modeling of aggregated data rather than direct causation.

What this means for you:
Optimal exercise dose for stroke mobility varies by type, with virtual reality evidence currently inconclusive.

Study Details

Study typeMeta analysis
EvidenceLevel 1
Follow-up540.0 mo
PublishedApr 2026
View Original Abstract ↓
OBJECTIVE: This study systematically evaluated the effects of both overall and modality-specific exercise doses on lower-limb functional mobility in middle-aged and older adults with stroke, and identified optimal dose-response relationships using Bayesian non-linear modeling. METHODS: Twenty-five randomized controlled trials involving 788 stroke patients aged ≥45 years were included. Lower-limb function was assessed using the Timed Up and Go test. Exercise dose was standardized as MET·min/week, incorporating frequency, duration, and intensity. Bayesian model-based network meta-analysis was used to estimate non-linear dose-response curves across six intervention modalities: gait training, motor control training, resistance training, integrated aerobic training, combined cognitive-exercise training, and virtual reality training. RESULTS: A non-linear association was observed between overall exercise dose and functional mobility improvement, with a peak effect (SMD ≈ 0.45) at approximately 1400 MET·min/week. Optimal dose zones varied across modalities: resistance and gait training showed strong effects at low doses (∼560 MET·min/week), integrated aerobic and combined cognitive-exercise training peaked at higher doses (∼1700-1800 MET·min/week), while motor control training achieved significant effects (∼SMD 0.50) at moderate doses (∼890 MET·min/week). Virtual reality training exhibited wide credible intervals and non-significant effects. CONCLUSION: This study demonstrates that lower-limb functional mobility in stroke patients follows a clear moderate-dose optimal pattern, with improvements peaking at around 1400 MET·min/week. Modality-specific analyses show that exercise approaches do not differ in inherent superiority but instead present distinct dose-response profiles. Evidence for virtual reality training remains inconclusive due to wide credible intervals. These findings provide quantitative guidance for dose-informed, individualized exercise prescriptions in neurorehabilitation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.